Search results
PROMOTED
Rhythm Interventions Online is back! Mark your calendars for Thursday 20 and Friday 21 November, as we bring you the most dynamic and immersive virtual experience in electrophysiology and cardiac rhythm management.
After five hugely successful editions, RIO has cemented its place as a must-attend global event, delivering world-class education to thousands of healthcare professionals worldwide.
…
View more
RIO 2025 - Day One | Global
Start date:
Nov 20, 2025
Broadcast
Added:
2 weeks ago
HRS Congress 2026 – Prof Lucas Boersma (St. Antonius Hospital, Nieuwegein, NL) joins us to discuss real-world periprocedural outcomes from the Enlighten post-market registry study evaluating the extravascular implantable cardioverter-defibrillator (EV-ICD) system, and how these compare to findings from pre-market clinical trials.The Enlighten study is an ongoing, global, prospective post-market…
View more
Added:
2 weeks ago
HRS Congress 2026 — Prof Ulrich Schotten (Maastricht University, Maastricht, NL) joins us to discuss new findings from the NOAH-AFNET 6 trial examining the distribution of atrial fibrillation burden, its relationship to clinical outcomes, and the effectiveness and safety of anticoagulation based on device reports.NOAH-AFNET 6 (Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial…
View more
Added:
2 weeks ago
HRS Congress 2026 — In this Arrhythmia Academy expert interview, Brad Wilson, Director of Medical Device Partnerships at Radcliffe and Arrhythmia Academy, speaks with Dr. Pasquale Santangeli (Cleveland Clinic, Ohio, USA) about six-month outcomes from the Sphere-9 VT early feasibility study.They review the Affera Sphere-9 lattice tip catheter and mapping-ablation system, a dual-energy, large…
View more
Added:
1 month ago
EHRA 2026 — Dr Kent Nilsson (Piedmont Athens Regional Hospital, Athens, GA, USA) joins us to discuss 1-year outcomes from the ARRIVE study, evaluating the Abbott Aveir AR atrial leadless pacemaker against single-chamber atrial transvenous pacemakers in a real-world Medicare population.This prospective, observational coverage with evidence development (CED) study leverages real-world data from…
View more
Added:
3 weeks ago
Added:
3 months ago
AF Symposium 2026 - Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, New York, NY, US) joins us to discuss findings from the ADVENT LTO study, evaluating long-term outcomes and atrial fibrillation progression in patients who received ablation with the FARAPULSE Pulsed Field Ablation System compared to thermal ablation.The study tracked AF progression patterns, arrhythmia recurrence rates,…
View more
Added:
1 month ago
EHRA Congress 2026 – Prof Roland Tilz (University Hospital Schleswig-Holstein, Lübeck, DE) presents the findings from the TiFFANY-AF study, a retrospective observational analysis evaluating real-world mortality outcomes associated with pulsed field ablation compared with thermal ablation techniques — radiofrequency and cryoballoon — for atrial fibrillation.Drawing on a decade of data from the US…
View more
Real-world Outcomes of AVNA: 10-year Results
Added:
3 months ago
Original Research
1-year Outcomes of PPI after TAVR: CONDUCT Registry: A PSM Comparison
Added:
11 months ago
Original Research